标题
Current and promising novel drug candidates against visceral leishmaniasis
作者
关键词
-
出版物
PURE AND APPLIED CHEMISTRY
Volume 91, Issue 8, Pages 1385-1404
出版商
Walter de Gruyter GmbH
发表日期
2019-06-13
DOI
10.1515/pac-2018-1102
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Identification of a 4-fluorobenzyl l -valinate amide benzoxaborole ( AN11736 ) as a potential development candidate for the treatment of Animal African Trypanosomiasis (AAT)
- (2018) Tsutomu Akama et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Recent advances of imidazole-containing derivatives as anti-tubercular agents
- (2018) Yi-Lei Fan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Benzoxaborole compounds for therapeutic uses: a patent review (2010- 2018)
- (2018) Alessio Nocentini et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- A new chimeric triple reporter fusion protein as a tool for in vitro and in vivo multimodal imaging to monitor the development of African trypanosomes and Leishmania parasites
- (2018) Estefania Calvo-Alvarez et al. INFECTION GENETICS AND EVOLUTION
- Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial
- (2018) Victor Kande Betu Ku Mesu et al. LANCET
- Benzoxaborole treatment perturbs S-adenosyl-L-methionine metabolism in Trypanosoma brucei
- (2018) Pieter C. Steketee et al. PLoS Neglected Tropical Diseases
- In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series
- (2018) M. Van den Kerkhof et al. International Journal for Parasitology-Drugs and Drug Resistance
- Leishmaniasis
- (2018) Sakib Burza et al. LANCET
- Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis
- (2018) Susan Wyllie et al. NATURE
- Clinical and veterinary trypanocidal benzoxaboroles target CPSF3
- (2018) Richard J. Wall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The trypanocidal benzoxaborole AN7973 inhibits trypanosome mRNA processing
- (2018) Daniela Begolo et al. PLoS Pathogens
- Chagas disease in Europe: A review for the internist in the globalized world
- (2017) Spinello Antinori et al. European Journal of Internal Medicine
- Investigation of in vitro absorption, distribution, metabolism, and excretion and in vivo pharmacokinetics of paromomycin: Influence on oral bioavailability
- (2017) MJakir S K. Pinjari et al. INDIAN JOURNAL OF PHARMACOLOGY
- Visceral leishmaniasis relapse hazard is linked to reduced miltefosine exposure in patients from Eastern Africa: a population pharmacokinetic/pharmacodynamic study
- (2017) Thomas P C Dorlo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The care and feeding of a commercial liposomal product: liposomal amphotericin B (AmBisome®)
- (2017) Gerard M. Jensen JOURNAL OF LIPOSOME RESEARCH
- Neglected tropical diseases: progress towards addressing the chronic pandemic
- (2017) David H Molyneux et al. LANCET
- Expression profiling of Sudanese visceral leishmaniasis patients pre- and post-treatment with sodium stibogluconate
- (2017) M. A. M. Salih et al. PARASITE IMMUNOLOGY
- Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India
- (2017) Saumya Srivastava et al. Parasites & Vectors
- Chemotherapeutics of visceral leishmaniasis: present and future developments
- (2017) SHYAM SUNDAR et al. PARASITOLOGY
- Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art
- (2017) REBECCA L. CHARLTON et al. PARASITOLOGY
- Imaging visceral leishmaniasis in real time with golden hamster model: Monitoring the parasite burden and hamster transcripts to further characterize the immunological responses of the host
- (2017) Eline Rouault et al. PARASITOLOGY INTERNATIONAL
- Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh
- (2017) Ridwanur Rahman et al. PLoS Neglected Tropical Diseases
- Towards elimination of visceral leishmaniasis in the Indian subcontinent—Translating research to practice to public health
- (2017) Siddhivinayak Hirve et al. PLoS Neglected Tropical Diseases
- Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions
- (2016) Neil R. H. Stone et al. DRUGS
- Repositioning Antitubercular 6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]oxazoles for Neglected Tropical Diseases: Structure–Activity Studies on a Preclinical Candidate for Visceral Leishmaniasis
- (2016) Andrew M. Thompson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
- (2016) Shilpi Khare et al. NATURE
- A review of visceral leishmaniasis during the conflict in South Sudan and the consequences for East African countries
- (2016) Waleed Al-Salem et al. Parasites & Vectors
- Leishmania infantum: illness, transmission profile and risk factors for asymptomatic infection in an endemic metropolis in Brazil
- (2016) LETÍCIA HELENA DOS SANTOS MARQUES et al. PARASITOLOGY
- Status of vaccine research and development of vaccines for leishmaniasis
- (2016) Portia M. Gillespie et al. VACCINE
- Current status on prevention and treatment of canine leishmaniasis
- (2016) Rosa M. Reguera et al. VETERINARY PARASITOLOGY
- Longitudinal Study of Transmission in Households with Visceral Leishmaniasis, Asymptomatic Infections and PKDL in Highly Endemic Villages in Bihar, India
- (2016) Vidya Nand Ravi Das et al. PLoS Neglected Tropical Diseases
- Identification of Trypanocidal Activity for Known Clinical Compounds Using a New Trypanosoma cruzi Hit-Discovery Screening Cascade
- (2016) Manu De Rycker et al. PLoS Neglected Tropical Diseases
- Activation of Bicyclic Nitro-drugs by a Novel Nitroreductase (NTR2) in Leishmania
- (2016) Susan Wyllie et al. PLoS Pathogens
- The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis
- (2016) Stephen Patterson et al. eLife
- The Chemical Space Project
- (2015) Jean-Louis Reymond ACCOUNTS OF CHEMICAL RESEARCH
- In VivoSelection of Paromomycin and Miltefosine Resistance in Leishmania donovani and L. infantum in a Syrian Hamster Model
- (2015) S. Hendrickx et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Trypanosomatids see the light: recent advances in bioimaging research
- (2015) Estefanía Calvo-Álvarez et al. DRUG DISCOVERY TODAY
- Novel Amino-pyrazole Ureas with Potent In Vitro and In Vivo Antileishmanial Activity
- (2015) Charles E. Mowbray et al. JOURNAL OF MEDICINAL CHEMISTRY
- Arsenic, antimony, and Leishmania: has arsenic contamination of drinking water in India led to treatment- resistant kala-azar?
- (2015) Meghan Perry et al. LANCET
- Studies of genotoxicity and mutagenicity of nitroimidazoles: demystifying this critical relationship with the nitro group
- (2015) Núbia Boechat et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Hit and lead criteria in drug discovery for infectious diseases of the developing world
- (2015) Kei Katsuno et al. NATURE REVIEWS DRUG DISCOVERY
- Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh
- (2015) Kazi M. Jamil et al. PLoS Neglected Tropical Diseases
- Generation of Luciferase-Expressing Leishmania infantum chagasi and Assessment of Miltefosine Efficacy in Infected Hamsters through Bioimaging
- (2015) Juliana Q. Reimão et al. PLoS Neglected Tropical Diseases
- Infrared Fluorescent Imaging as a Potent Tool for In Vitro, Ex Vivo and In Vivo Models of Visceral Leishmaniasis
- (2015) Estefanía Calvo-Álvarez et al. PLoS Neglected Tropical Diseases
- Bioluminescence imaging of chronicTrypanosoma cruziinfections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection
- (2014) Michael D. Lewis et al. CELLULAR MICROBIOLOGY
- Recent Developments in Drug Discovery for Leishmaniasis and Human African Trypanosomiasis
- (2014) Advait S. Nagle et al. CHEMICAL REVIEWS
- An update on pharmacotherapy for leishmaniasis
- (2014) Shyam Sundar et al. EXPERT OPINION ON PHARMACOTHERAPY
- An overview of visceral leishmaniasis elimination program in India: a picture imperfect
- (2014) Ubhayabharathi Gurunath et al. Expert Review of Anti-Infective Therapy
- Post kala-azar dermal leishmaniasis: an unresolved mystery
- (2014) Debanjan Mukhopadhyay et al. TRENDS IN PARASITOLOGY
- Visceral Leishmaniasis and HIV Coinfection in Latin America
- (2014) José Angelo Lindoso et al. PLoS Neglected Tropical Diseases
- Visceral Leishmaniasis and HIV Coinfection in East Africa
- (2014) Ermias Diro et al. PLoS Neglected Tropical Diseases
- Unveiling the Intracellular Survival Gene Kit of Trypanosomatid Parasites
- (2014) Daniella Castanheira Bartholomeu et al. PLoS Pathogens
- TheREnantiomer of the Antitubercular Drug PA-824 as a Potential Oral Treatment for Visceral Leishmaniasis
- (2013) Stephen Patterson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- From On-Target to Off-Target Activity: Identification and Optimisation ofTrypanosoma bruceiGSK3 Inhibitors and Their Characterisation as Anti-Trypanosoma bruceiDrug Discovery Lead Molecules
- (2013) Andrew Woodland et al. ChemMedChem
- Re-emergence of leishmaniasis in Spain: community outbreak in Madrid, Spain, 2009 to 2012
- (2013) A Arce et al. Eurosurveillance
- Toxicokinetic and mechanistic basis for the safety and tolerability of liposomal amphotericin B
- (2013) Angela S Loo et al. Expert Opinion On Drug Safety
- Immunomodulatory effects of antileishmanial drugs
- (2013) M. Ghosh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Molecular and serological markers ofLeishmania donovaniinfection in healthy individuals from endemic areas of Bihar, India
- (2013) Pankaj Srivastava et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Application of population pharmacokinetics for preclinical safety and efficacy studies
- (2013) Stefano Porzio Bioanalysis
- A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis
- (2013) Peter Babokhov et al. Pathogens and Global Health
- Liposomal amphotericin B as a treatment for human leishmaniasis
- (2012) Manica Balasegaram et al. EXPERT OPINION ON EMERGING DRUGS
- Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis
- (2012) T. P. C. Dorlo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- An Image-Based High-Content Screening Assay for Compounds Targeting Intracellular Leishmania donovani Amastigotes in Human Macrophages
- (2012) Jair L. Siqueira-Neto et al. PLoS Neglected Tropical Diseases
- Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?
- (2012) Lucio H. Freitas-Junior et al. International Journal for Parasitology-Drugs and Drug Resistance
- Antitrypanosomal Activity of Fexinidazole, a New Oral Nitroimidazole Drug Candidate for Treatment of Sleeping Sickness
- (2011) Marcel Kaiser et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani
- (2011) Bidyut Purkait et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Leishmaniasis chemotherapy—challenges and opportunities
- (2011) S.L. Croft et al. CLINICAL MICROBIOLOGY AND INFECTION
- Trypanosoma cruzi and Chagas' Disease in the United States
- (2011) C. Bern et al. CLINICAL MICROBIOLOGY REVIEWS
- Trypanocidal Activity of Nitroaromatic Prodrugs: Current Treatments and Future Perspectives
- (2011) Shane R. Wilkinson et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Benzoxaboroles: a new class of potential drugs for human African trypanosomiasis
- (2011) Robert T Jacobs et al. Future Medicinal Chemistry
- The cost of drug development: A systematic review
- (2011) Steve Morgan et al. HEALTH POLICY
- Identification of Small Molecule Lead Compounds for Visceral Leishmaniasis Using a Novel Ex Vivo Splenic Explant Model System
- (2011) Yaneth Osorio et al. PLoS Neglected Tropical Diseases
- Discovery of Novel Orally Bioavailable Oxaborole 6-Carboxamides That Demonstrate Cure in a Murine Model of Late-Stage Central Nervous System African Trypanosomiasis
- (2010) B. Nare et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Principles of early drug discovery
- (2010) JP Hughes et al. BRITISH JOURNAL OF PHARMACOLOGY
- Application of In Vivo Animal Models to Characterize the Pharmacokinetic and Pharmacodynamic Properties of Drug Candidates in Discovery Settings
- (2010) Benny Amore et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- Clinical Efficacy and Pharmacokinetics of Antimony in Cutaneous Leishmaniasis Patients Treated With Sodium Stibogluconate
- (2010) Iman Y. Zaghloul et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Socioeconomic aspects of neglected tropical diseases
- (2010) Lesong Conteh et al. LANCET
- Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India
- (2010) Shyam Sundar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antimony Toxicity
- (2010) Shyam Sundar et al. International Journal of Environmental Research and Public Health
- Paromomycin for the Treatment of Visceral Leishmaniasis in Sudan: A Randomized, Open-Label, Dose-Finding Study
- (2010) Ahmed M. Musa et al. PLoS Neglected Tropical Diseases
- Cost-Effectiveness Analysis of Combination Therapies for Visceral Leishmaniasis in the Indian Subcontinent
- (2010) Filip Meheus et al. PLoS Neglected Tropical Diseases
- Red-emitting luciferases for bioluminescence reporter and imaging applications
- (2009) Bruce R. Branchini et al. ANALYTICAL BIOCHEMISTRY
- Safety, Tolerability, and Pharmacokinetics of PA-824 in Healthy Subjects
- (2009) A. M. Ginsberg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Triggering of Suicidal Erythrocyte Death by Amphotericin B
- (2009) Hasan Mahmud et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Miltefosine Promotes IFN- -Dominated Anti-Leishmanial Immune Response
- (2009) P. Wadhone et al. JOURNAL OF IMMUNOLOGY
- Pentavalent Antimonials: New Perspectives for Old Drugs
- (2009) Frédéric Frézard et al. MOLECULES
- Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis
- (2008) E. Nuermberger et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Amphotericin B Formulations and Drug Targeting
- (2007) J.J. Torrado et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started